Placebo News and Research

RSS

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys.

14 Oct 2016

Mild sedative could reduce risk of post-operative delirium

A mild sedative could greatly reduce the risk of people experiencing delirium after an operation, according to new research.

14 Oct 2016

Knowingly taking placebo pills can help alleviate chronic back pain, study finds

Conventional medical wisdom has long held that placebo effects depend on patients' belief they are getting pharmacologically active medication.

14 Oct 2016

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.

14 Oct 2016

Clinical study to determine safety, efficacy of allogeneic CDCs for patients with myocardial infarction

A multi-center team of researchers are planning a clinical trial using cardiosphere-derived cells (CDCs) (a heterogeneous cluster of proliferating cardiac cells that include mesenchymal stem cells) to regenerate the tissue and improve function of the heart in patients who have suffered heart attacks (myocardial infarction, MI).

13 Oct 2016

Study to investigate clinical impact of new treatment for HFrEF patients

The academic partners in the VerICiguaT GlObal Study in Subjects with Heart Failure with Reduced EjectIon FrAction are pleased to announce that patient enrollment has begun.

12 Oct 2016

DHA supplementation enhances cognitive function in older adults with MCI

Results from a recent study published in the Journal of Alzheimer's Disease support the cognitive benefits of DHA, which have been consistently demonstrated with doses of 900 mg/day or greater.

12 Oct 2016

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Botanical supplements are used by people around the world to treat a wide range of physical and mental ailments. Some of these botanical supplements have high levels of antioxidants, which may have some positive health effects for certain conditions.

12 Oct 2016

Study to examine efficacy of orally administered medication in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known.

8 Oct 2016

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer, researchers reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

8 Oct 2016

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented for the first time today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds

Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.

7 Oct 2016

RTI extends research support to improve treatment for pelvic floor disorders in women

RTI International will continue supporting research efforts to improve clinical care for women with pelvic floor disorders as part of the Pelvic Floor Disorders Network.

6 Oct 2016

UAB researchers launch first drug study to prevent onset of epilepsy in children with TSC

Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.

6 Oct 2016

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

In the past vitamin D was just thought to be important in regulating calcium homeostasis and bone health as vitamin D deficiency is best known for causing rickets in children and osteomalacia in adults.

4 Oct 2016

New research shows oxytocin may increase sense of spirituality

Oxytocin has been dubbed the "love hormone" for its role promoting social bonding, altruism and more. Now new research from Duke University suggests the hormone may also support spirituality.

4 Oct 2016

Trial evaluates efficacy of chiropractic spinal manipulative therapy for treating migraines

Manual-therapy randomized controlled trials (RCTs) are difficult to perform because it's challenging to conceal a placebo when patients are able to physically feel a treatment that's being delivered.

3 Oct 2016

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer's disease.

30 Sep 2016

Study evaluates effects of spearmint, rosemary extracts on learning and memory in SAMP8 mouse model

A recently published medical school study shows Kemin's proprietary antioxidant-based ingredients, spearmint extract and rosemary extract, improve learning and memory in SAMP8 mice.

30 Sep 2016

Placebo News and Research

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Mild sedative could reduce risk of post-operative delirium

Knowingly taking placebo pills can help alleviate chronic back pain, study finds

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

Clinical study to determine safety, efficacy of allogeneic CDCs for patients with myocardial infarction

Study to investigate clinical impact of new treatment for HFrEF patients

DHA supplementation enhances cognitive function in older adults with MCI

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Study to examine efficacy of orally administered medication in treating stuttering

Combination treatment with CDK4/6 inhibitor improves progression-free survival in HR+ breast cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds

RTI extends research support to improve treatment for pelvic floor disorders in women

UAB researchers launch first drug study to prevent onset of epilepsy in children with TSC

Can vitamin D reduce asthma attacks? An interview with Professor Adrian Martineau

New research shows oxytocin may increase sense of spirituality

Trial evaluates efficacy of chiropractic spinal manipulative therapy for treating migraines

GUMC receives FDA clearance to begin clinical study of cancer drug in patients with Alzheimer's disease

Study evaluates effects of spearmint, rosemary extracts on learning and memory in SAMP8 mouse model

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News